Mabel Chan, PharmD, BCACP

Researchers assessed the safety and efficacy of standard care plus anakinra vs standard care alone among patients with severe COVID-19 pneumonia and hyperinflammation.

Researchers examined the effects of different COVID-19 variants and vaccination status on the risk for postacute sequelae symptoms.